Octillion Announces Appointment of Mr. Joseph Sierchio, Esq. to Board of Directors
2008-07-24 11:22:00
Octillion Announces Appointment of Mr. Joseph Sierchio, Esq. to Board of Directors
AUBURN HILLS, Mich.–(EMWNews)–Octillion Corp. (OTCBB:OCTL), a next-generation alternative and
renewable energy technology incubator, today announced the appointment
of Mr. Joseph Sierchio, Esq., an attorney with over three decades of
experience in corporate finance and securities law, to the Company’s
Board of Directors.
Mr. Joseph Sierchio earned his Doctor of Law degree at Cornell
University Law School in 1974, and a Bachelor of Arts degree, with
Highest Distinction in Economics, from Rutgers College at Rutgers
University, in 1971.
“Mr. Sierchio brings us 33 years of experience
in the aspects of corporate law that are most relevant to a public
company like Octillion,” stated Mr. Nicholas
Cucinelli, President and CEO of Octillion Corp. “Joe’s
hands-on expertise with regulatory compliance, mergers and acquisitions,
and institutional financing, as well as his considerable experience in
the alternative energy sector, make for a welcome addition to our Board.”
Since 1975, Mr. Joseph Sierchio has practiced corporate and securities
law in New York City, representing and offering counsel to domestic and
foreign corporations, investors, entrepreneurs, and public and private
companies in the United States, Canada, United Kingdom, Germany, Italy,
Switzerland, Australia, and Hong Kong. Mr. Sierchio is admitted in all
New York state courts and federal courts in the Eastern, Northern, and
Southern Districts of the State of New York as well as the federal Court
of Appeals for the Second Circuit. Mr. Sierchio is also a member of
Sierchio & Company, LLP, counsel to the Company.
About Octillion Corp.
Octillion Corp., together with its wholly owned subsidiaries, is a next
generation technology incubator focused on the identification,
acquisition, development, and commercialization of alternative and
renewable energy technologies.
Through established relationships with universities, research
institutions, government agencies, and start-up companies, we strive to
identify technologies and business opportunities on the leading edge of
innovation that have the potential of serving significant and unmet
market needs.
Once a technology has been identified, we fund the research and
development activities relating to the technology with the intention of
ultimately, if warranted, licensing, commercializing and marketing the
subject technology, either through internal resources, collaborative
agreements or otherwise.
Unique to our business model is the use of established research
infrastructure owned by the various organizations we work with, saving
us significant capital which would otherwise be required for such things
as land and building acquisition, equipment and furniture purchases, and
other incidental start up costs. As a result, we are able to benefit
from leading edge research and development while employing significantly
less capital than conventional organizations.
Among our current research and development activities is the development
of a technology that could adapt existing home and office glass windows
into ones capable of generating electricity from solar energy without
losing significant transparency or requiring major changes in
manufacturing infrastructure.
The technological potential of adapting existing glass windows into ones
capable of generating electricity from the sun’s
solar energy has been made possible through a ground breaking discovery
of an electrochemical and ultrasound process that produces identically
sized (1 to 4 nanometers in diameter) highly luminescent nanoparticles
of silicon that provide varying wavelengths of photoluminescence with
high quantum down conversion efficiency of short wavelengths (50% to
60%).
When thin films of silicon nanoparticles are deposited (sprayed) onto
silicon substrates, ultraviolet light is absorbed and converted into
electrical current. With appropriate connections, the films act as
nanosilicon photovoltaic solar cells that convert solar radiation to
electrical energy.
We are also developing a system to harness the kinetic energy of
vehicles in motion as part of a broader effort to enhance the
sustainability and energy efficiency of transportation infrastructures
and systems.
For additional information, please visit: www.octillioncorp.com
To receive future press releases via email, please visit:
http://www.octillioncorp.com/contact.html
To view the full HTML text of this release, please visit:
http://Octillioncorp.com/OCTL_20080724.html
Legal Notice Regarding Forward-Looking
Statements
No statement herein should be considered an offer or a solicitation of
an offer for the purchase or sale of any securities. This release
contains forward-looking statements that are based upon current
expectations or beliefs, as well as a number of assumptions about future
events. Although Octillion Corp. (the “Company”
or “Octillion”)
believes that the expectations reflected in the forward-looking
statements and the assumptions upon which they are based are reasonable,
it can give no assurance that such expectations and assumptions will
prove to have been correct. Forward-looking statements, which involve
assumptions and describe our future plans, strategies, and expectations,
are generally identifiable by use of the words “may,”
“will,” “should,”
“could,” “expect,”
“anticipate,” “estimate,”
“believe,” “intend,”
or “project” or
the negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements are
subject to numerous factors and uncertainties, including but not limited
to adverse economic conditions, intense competition, lack of meaningful
research results, entry of new competitors and products, adverse
federal, state and local government regulation, inadequate capital,
unexpected costs and operating deficits, increases in general and
administrative costs, termination of contracts or agreements,
technological obsolescence of the Company’s products, technical problems
with the Company’s research and products, price increases for supplies
and components, litigation and administrative proceedings involving the
Company, the possible acquisition of new businesses or technologies that
result in operating losses or that do not perform as anticipated,
unanticipated losses, the possible fluctuation and volatility of the
Company’s operating results, financial condition and stock price, losses
incurred in litigating and settling cases, dilution in the Company’s
ownership of its business, adverse publicity and news coverage,
inability to carry out research, development and commercialization
plans, loss or retirement of key executives and research scientists,
changes in interest rates, inflationary factors, and other specific
risks. We currently have no commercial products intended to diagnose,
treat, prevent or cure any disease. The statements contained in this
press release regarding our on going research and development and the
results attained by us to-date have not been evaluated by the Food and
Drug Administration. There can be no assurance that further research and
development, and /or whether clinical trial results, if any, will
validate and support the results of our preliminary research and
studies. Further, there can be no assurance that the necessary
regulatory approvals will be obtained or that Octillion will be able to
develop commercially viable products on the basis of its technologies.
In addition, other factors that could cause actual results to differ
materially are discussed in the Company’s most recent Form 10-QSB and
Form 10-KSB filings with the Securities and Exchange Commission. These
reports and filings may be inspected and copied at the Public Reference
Room maintained by the U.S. Securities & Exchange Commission at 100 F
Street, N.E., Washington, D.C. 20549. You can obtain information about
operation of the Public Reference Room by calling the U.S. Securities &
Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange
Commission also maintains an Internet site that contains reports, proxy
and information statements, and other information regarding issuers that
file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov.
The Company undertakes no obligation to publicly release the results of
any revisions to these forward looking statements that may be made to
reflect the events or circumstances after the date hereof or to reflect
the occurrence of unanticipated events.
Octillion Corp. |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions